Type
Blood Testing
Biomarkers
2
Duration
15 min
Sample
Blood (venous)
What's included
5 deliverables in this treatment
- CA 19-9
- CEA (carcinoembryonic antigen)
- CA 15-3
- CA 125
- Venous blood draw at the collection point
A blood panel measuring four tumour markers relevant to women, intended as a screening adjunct rather than a diagnostic test on its own. For 160 zł it covers CA 19-9, CEA, CA 15-3 and CA 125. It may be chosen by people wanting these markers checked as part of broader monitoring or because of family history. Tumour-marker results are non-specific and are always interpreted by a physician alongside other findings.
About this treatment
The Tumour Marker Panel for women measures four blood markers — CA 19-9, CEA (carcinoembryonic antigen), CA 15-3 and CA 125 — that are sometimes used as adjuncts in monitoring and screening contexts, packaged at 160 zł. These markers are proteins that can be present at varying levels in the blood, and the panel offers a convenient way to have them measured together. It is important to understand what such a panel is and is not: tumour markers are…
For that reason the panel is positioned as a screening adjunct rather than a standalone diagnostic test, and results are always meant to be interpreted by a physician in the context of your history, symptoms, imaging and any other tests. People who choose it often do so as part of broader health monitoring, because of a relevant family history, or on the advice of a clinician who wants these values tracked over time. Blood is drawn at the al. Wyzwolenia 7…
Good to know
- Markers
- 4 tumour markers
- Use
- Screening adjunct, not a diagnosis
- Lab
- Processed via ALAB laboratoria
Who is this for?
People wanting these markers tracked as part of broader monitoring, reviewed with a physician
Preparation required
No special preparation is usually required; results should be reviewed with a physician.
Panel categories
Biomarkers tested
2A biomarker associated with some breast cancers; used to monitor treatment response in patients with metastatic breast cancer.
A biomarker commonly used in the diagnosis and management of pancreatic and gastrointestinal cancers. Elevated levels can also be found in other conditions such as liver disease.
About the clinic
Reviews, team and credentials
Independent review links and clinic-reported team information.
1,329 clinic reviews
From independent platforms
Clinical team
Pramed is staffed by internal-medicine physicians (including lek. Dorota Łuczak-Gutowska, lek. Małgorzata Tylutki-Pilek, lek. Dorota Wysokińska and lek. Robert Golonka), a family-medicine specialist (dr n. med. Anna Gilewska) and ultrasound specialists (dr n. med. Piotr Gołofit and colleagues). Laboratory analysis of collected samples is carried out in partnership with ALAB laboratoria.
Languages: Polish
Treatment highlights
- CA 19-9
- CEA (carcinoembryonic antigen)
+3 more items in What's included
160 zł for the women's tumour-marker panel, including the blood draw. Tumour markers are a screening adjunct, not a standalone diagnosis — results should be reviewed with a physician.